Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis

Technology in Cancer Research and Treatment

Volumn 14, Issue 6, 2015, Pages 667-676

  Bahig, Houda ^a   Filion, Edith ^a   Vu, Toni ^a   Roberge, David ^a   Lambert, Louise ^a   Bouchard, Myriam ^b   Lavoie, Caroline ^c   Doucet, Robert ^a   Nadeau, Dominic Béliveau ^a   Chalaoui, Jean ^a   Campeau, Marie Pierre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Cyberknife; Lung SBRT; Prognostic factors; Pulmonary fibrosis

Indexed keywords

ADVERSE EFFECTS; AGED; ALGORITHM; CARCINOMA, NON-SMALL-CELL LUNG; COMPLICATION; DISEASE FREE SURVIVAL; FEMALE; FIBROSING ALVEOLITIS; HUMAN; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PROCEDURES; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY PLANNING SYSTEM; RETROSPECTIVE STUDY; ROBOTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; ROBOTICS;

EID: 84988837933     PISSN: 15330346     EISSN: 15330338     Source Type: Journal    
DOI: 10.7785/TCRT.2012.500445     Document Type: Article

References (36)

1. Parkin, D. M., Bray, F., Ferlay, J., Pisani, P. Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 94, 153-156 (2001). DOI: 10.1002/ijc.1440
2. Solda, F., Lodge, M., Ashley, S., Whitington, A., Goldstraw, P., Brada, M. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer. Systematic review and comparison with a surgical cohort. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 109, 1-7 (2013). DOI: 10.1016/j.radonc.2013.09.006
3. Timmerman, R., Paulus, R., Galvin, J., Michalski, J., Straube, W., Bradley, J., Fakiris, A., Bezjak, A., Videtic, G., Johnstone, D., Fowler, J., Gore, E., Choy, H. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA: the Journal of the American Medical Association 303, 1070-1076 (2010). DOI: 10.1001/jama.2010.261
4. Brown, W. T., Wu, X., Amendola, B., Perman, M., Han, H., Fayad, F., Garcia, S., Lewin, A., Abitbol, A., de la Zerda, A., Schwade, J. G. Treatment of early non-small cell lung cancer, stage IA, by imageguided robotic stereotactic radioablation–CyberKnife. Cancer J 13, 87-94 (2007). DOI: 10.1097/PPO.0b013e31803c5415
5. Brown, W. T., Wu, X., Fayad, F., Fowler, J. F., Amendola, B. E., Garcia, S., Han, H., de la Zerda, A., Bossart, E., Huang, Z., Schwade, J. G. CyberKnife radiosurgery for stage I lung cancer: results at 36 months. Clinical Lung Cancer 8, 488-492 (2007). DOI: 10.3816/ CLC.2007.n.033
6. Lagerwaard, F. J., Haasbeek, C. J., Smit, E. F., Slotman, B. J., Senan, S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 70, 685-692 (2008). DOI: 10.1016/ j.ijrobp.2007.10.053
7. Nagata, Y., Takayama, K., Matsuo, Y., Norihisa, Y., Mizowaki, T., Sakamoto, T., Sakamoto, M., Mitsumori, M., Shibuya, K., Araki, N., Yano, S., Hiraoka, M. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. International Journal of Radiation Oncology, Biology, Physics 63, 1427-1431 (2005). DOI: 10.1016/j.ijrobp.2005.05.034
8. Baumann, P., Nyman, J., Hoyer, M., Wennberg, B., Gagliardi, G., Lax, I., Drugge, N., Ekberg, L., Friesland, S., Johansson, K. A., Lund, J. A., Morhed, E., Nilsson, K., Levin, N., Paludan, M., Sederholm, C., Traberg, A., Wittgren, L., Lewensohn, R. Outcome in a prospective phase II trial of medically inoperable stage I non-smallcell lung cancer patients treated with stereotactic body radiotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27, 3290-3296 (2009). DOI: 10.1200/ JCO.2008.21.5681
9. Verstegen, N. E., Oosterhuis, J. W., Palma, D. A., Rodrigues, G., Lagerwaard, F. J., van der Elst, A., Mollema, R., van Tets, W. F., Warner, A., Joosten, J. J., Amir, M. I., Haasbeek, C. J., Smit, E. F., Slotman, B. J., Senan, S. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Annals of Oncology: Official Journal of the European Society for Medical Oncology (ESMO) 24, 1543-1548 (2013). DOI: 10.1093/annonc/mdt026
10. Louie, A. V., Rodrigues, G., Hannouf, M., Zaric, G. S., Palma, D. A., Cao, J. Q., Yaremko, B. P., Malthaner, R., Mocanu, J. D. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis. International Journal of Radiation Oncology, Biology, Physics 81, 964-973 (2011). DOI: 10.1016/j.ijrobp.2010.06.040
11. Timmerman, R., McGarry, R., Yiannoutsos, C., Papiez, L., Tudor, K., DeLuca, J., Ewing, M., Abdulrahman, R., DesRosiers, C., Williams, M., Fletcher, J. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 24, 4833-4839 (2006). DOI: 10.1200/JCO.2006.07.5937
12. Fu, D. K. R., Wang, B., Wang, H., Mu, Z., Kuduvalli, G., et al. Fiducial-free lung tumor tracking of cyberknife radiosurgery. International Journal of Radiation Oncology, Biology, Physics, S608-609 (2008). DOI: 10.1016/j.ijrobp.2008.06.235
13. Bahig, H., Campeau, M. P., Vu, T., Doucet, R., Beliveau Nadeau, D., Fortin, B., Roberge, D., Lambert, L., Carrier, J. F., Filion, E. Predictive parameters of cyberknife fiducial-less (XSight lung) applicability for treatment of early non-small cell lung cancer: a single-center experience. International Journal of Radiation Oncology, Biology, Physics (2013). DOI: 10.1016/j.ijrobp.2013.06.2048
14. Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., Gwyther, S. G. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. Journal of the National Cancer Institute 92, 205-216 (2000). DOI: 10.1093/jnci/92.3.205
15. Zhang, J., Yang, F., Li, B., Li, H., Liu, J., Huang, W., Wang, D., Yi, Y., Wang, J. Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis. International Journal of Radiation Oncology, Biology, Physics 81, e305-316 (2011). DOI: 10.1016/j.ijrobp.2011.04.034
16. Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., Gomi, K., Niibe, Y., Karasawa, K., Hayakawa, K., Takai, Y., Kimura, T., Takeda, A., Ouchi, A., Hareyama, M., Kokubo, M., Hara, R., Itami, J., Yamada, K., Araki, T. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer 2, S94-100 (2007). DOI: 10.1097/ JTO.0b013e318074de34
17. Grills, I. S., Mangona, V. S., Welsh, R., Chmielewski, G., McInerney, E., Martin, S., Wloch, J., Ye, H., Kestin, L. L. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 28, 928-935 (2010). DOI: 10.1200/JCO.2009.25.0928
18. Ginsberg, R. J., Rubinstein, L. V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. The Annals of thoracic surgery 60, 615-622; discussion 622-613 (1995). DOI: 10.1016/0003-4975(95)00537-U
19. Powell, H. A., Tata, L. J., Baldwin, D. R., Stanley, R. A., Khakwani, A., Hubbard, R. B. Early mortality after surgical resection for lung cancer: an analysis of the english national lung cancer audit. Thorax 68, 826-834 (2013). DOI: 10.1136/thoraxjnl-2012-203123
20. Senthi, S., Haasbeek, C. J., Slotman, B. J., Senan, S. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 106, 276-282 (2013). DOI: 10.1016/j.radonc.2013.01.004
21. Dunlap, E., Larner, M. J., Read, W. P., Benjamin, D. K., Lau, L. C., Shng, K., Jones, D. R. Size matters: A comparison of T1 and T2 peripheral non-small cell lung cancers treated with stereotactic body radiotherapy (SBRT). Journal of Thoracic and Cardiovascular Surgery 140, 583-589 (2010). DOI: 10.1016/j.jtcvs.2010.01.046
22. Onishi, H., Shirato, H., Nagata, Y., Hiraoka, M., Fujino, M., Gomi, K., Karasawa, K., Hayakawa, K., Niibe, Y., Takai, Y., Kimura, T., Takeda, A., Ouchi, A., Hareyama, M., Kokubo, M., Kozuka, T., Arimoto, T., Hara, R., Itami, J., Araki, T. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? International Journal of Radiation Oncology, Biology, Physics 81, 1352-1358 (2011). DOI: 10.1016/ j.ijrobp.2009.07.1751
23. Hoyer, M. R. H., Hansen, A. T., Ohlhuis, L., Petersen, J., Nellemann, H., Berthelsen, A. K., Grau, C., Engelholm, S. A., von der Maase, H. Prospective study on stereotactic radiotherapy of limited-stage non–smallcell lung cancer. International Journal of Radiation Oncology, Biology, Physics 66, S128-S135 (2006). DOI: 10.1016/j.ijrobp.2006.01.012
24. Huang, K., Dahele, M., Senan, S., Guckenberger, M., Rodrigues, G. B., Ward, A., Boldt, R. G., Palma, D. A. Radiographic changes after lung stereotactic ablative radiotherapy (SABR)–can we distinguish recurrence from fibrosis? A systematic review of the literature. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 102, 335-342 (2012). DOI: 10.1016/j.radonc.2011.12.018
25. Huang, K., Senthi, S., Palma, D. A., Spoelstra, F. O., Warner, A., Slotman, B. J., Senan, S. High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 109, 51-57 (2013). DOI: 10.1016/j.radonc.2013.06.047
26. Yamashita, H., Nakagawa, K., Nakamura, N., Koyanagi, H., Tago, M., Igaki, H., Shiraishi, K., Sasano, N., Ohtomo, K. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2, 21 (2007). DOI: 10.1186/1748-717X-2-21
27. Guckenberger, M., Heilman, K., Wulf, J., Mueller, G., Beckmann, G., Flentje, M. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 85, 435-442 (2007). DOI: 10.1016/j.radonc.2007.10.044
28. Zimmermann, F. B., Geinitz, H., Schill, S., Thamm, R., Nieder, C., Schratzenstaller, U., Molls, M. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45, 796-801 (2006). DOI: 10. 1080/02841860600913210
29. Takeda, A., Enomoto, T., Sanuki, N., Nakajima, T., Takeda, T., Sayama, K., Kunieda, E. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiation Medicine 26, 504-507 (2008). DOI: 10.1007/s11604-008-0261-8
30. Takeda, A., Ohashi, T., Kunieda, E., Enomoto, T., Sanuki, N., Takeda, T., Shigematsu, N. Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors. International Journal of Radiation Oncology, Biology, Physics 77, 685-690 (2010). DOI: 10.1016/j.ijrobp.2009.06.001
31. Yamashita, H., Kobayashi-Shibata, S., Terahara, A., Okuma, K., Haga, A., Wakui, R., Ohtomo, K., Nakagawa, K. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol 5, 32 (2010). DOI: 10.1186/1748-717X-5-32
32. Yamaguchi, S., Ohguri, T., Ide, S., Aoki, T., Imada, H., Yahara, K., Narisada, H., Korogi, Y. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis. Lung Cancer 82, 260-265 (2013). DOI: 10.1016/j.lungcan.2013.08.024
33. Onishi, H. Y. S., Yasuo, M., Kenji, T., Yukinori, M., Akifumi, M., Hideomi, Y., Haruo, M., Masahiko, A., Keiji, N. Japanese multi-institutional study of stereotactic body radiation therapy for more than 2000 patients with stage I non small cell lung cancer. International Journal of Radiation Oncology * Biology * Physics 87, S9-S10 (2013). DOI: 10.1016/j.ijrobp.2013.06.031
34. Watanabe, A., Higami, T., Ohori, S., Koyanagi, T., Nakashima, S., Mawatari, T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? The Journal of Thoracic and Cardiovascular Surgery 136, 1357-1363, 1363 e1351-1352 (2008). DOI: 10.1016/j.jtcvs.2008.07.016
35. Donington, J., Ferguson, M., Mazzone, P., Handy, J. Jr., Schuchert, M., Fernando, H., Loo, B. Jr., Lanuti, M., de Hoyos, A., Detterbeck, F., Pennathur, A., Howington, J., Landreneau, R., Silvestri, G. American college of chest physicians and society of thoracic surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest 142, 1620- 1635 (2012). DOI: 10.1378/chest.12-0790
36. Chida, M., Ono, S., Hoshikawa, Y., Kondo, T. Subclinical idiopathic pulmonary fibrosis is also a risk factor of postoperative acute respiratory distress syndrome following thoracic surgery. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery 34, 878-881 (2008). DOI: 10.1016/j.ejcts.2008.07.028